10 insiders reported 32 Form 4 transactions for CITIUS ONCOLOGY, INC. (CTOR) over the past 18 months (most recent 2025-12-22). Recent activity: Dutia Suren G (Director) Buy 300,000 shares, Mazur Leonard L (Chief Executive Officer) Buy 1.7M shares, Mayersohn Joel David (Director) Buy 300,000 shares, Holuka Eugene Myron (Director) Buy 300,000 shares, Czuczman Myron (Chief Medical Officer) Buy 825,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-22 | Dutia Suren G | Director | Buy | 300,000 | $0 |
| 2025-12-22 | Mazur Leonard L | Chief Executive Officer | Buy | 1.7M | $0 |
| 2025-12-22 | Mayersohn Joel David | Director | Buy | 300,000 | $0 |
| 2025-12-22 | Holuka Eugene Myron | Director | Buy | 300,000 | $0 |
| 2025-12-22 | Czuczman Myron | Chief Medical Officer | Buy | 825,000 | $0 |
| 2025-12-22 | Webb Carol | Director | Buy | 300,000 | $0 |
| 2025-12-22 | MCGRATH DENNIS M | Director | Buy | 300,000 | $0 |
| 2025-12-22 | Smith Robert Joseph | Director | Buy | 300,000 | $0 |
| 2025-12-22 | Bartushak Jaime | Chief Financial Officer | Buy | 825,000 | $0 |
| 2025-12-22 | HOLUBIAK MYRON Z | Secretary | Buy | 850,000 | $0 |
| 2025-12-01 | Bartushak Jaime | Chief Financial Officer | Buy | 825,000 | $0 |
| 2025-12-01 | Webb Carol | Director | Buy | 300,000 | $0 |
| 2025-12-01 | Dutia Suren G | Director | Buy | 300,000 | $0 |
| 2025-12-01 | Mayersohn Joel David | Director | Buy | 300,000 | $0 |
| 2025-12-01 | Mazur Leonard L | Chief Executive Officer | Buy | 1.7M | $0 |
| 2025-12-01 | Smith Robert Joseph | Director | Buy | 300,000 | $0 |
| 2025-12-01 | MCGRATH DENNIS M | Director | Buy | 300,000 | $0 |
| 2025-12-01 | Holuka Eugene Myron | Director | Buy | 300,000 | $0 |
| 2025-12-01 | HOLUBIAK MYRON Z | Secretary | Buy | 850,000 | $0 |
| 2025-12-01 | Czuczman Myron | Chief Medical Officer | Buy | 825,000 | $0 |
| 2025-09-23 | HOLUBIAK MYRON Z | Secretary | Buy | 850,000 | $0 |
| 2025-09-23 | HOLUBIAK MYRON Z | Secretary | Buy | 100,000 | $0 |
| 2025-09-23 | Holuka Eugene Myron | Director | Buy | 300,000 | $0 |
| 2025-09-23 | Dutia Suren G | Director | Buy | 300,000 | $0 |
| 2025-09-23 | Bartushak Jaime | Chief Financial Officer | Buy | 825,000 | $0 |
Source: SEC Form 4 filings · as of 2025-12-22
